Gregory Alan Korbel - 10 Sep 2021 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Chief Business Officer
Signature
/s/ Scott M. Coiante, attorney-in-fact
Issuer symbol
APRE
Transactions as of
10 Sep 2021
Net transactions value
-$7,913
Form type
4
Filing time
14 Sep 2021, 17:01:08 UTC
Previous filing
27 Aug 2021
Next filing
22 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability $7,913 -1,724 -7.1% $4.59 22,627 10 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 5,000 restricted stock units.